EHS Meeting 2014

Wellcome Address
Dear Colleagues
On behalf of the Egyptian Hypertension Society (EHS) and Cardiology Department
at Suez Canal University ,Its our pleasure to invite you to participate in 17th Annual
Scientific meeting of the EHS which will be held from 9 th 10 th April 2014 at
Fairmont Heliopolis hotel Cairo , Egypt .
This year`s meeting will be organized conjointly by EHS and Cardiology
Department at Suez Canal University. As our practice in the past meetings, we do
our best to present state of the art presentations in the field of hypertension
addressing different domains, experimental research, clinical aspects, and different
problems encountered in management of hypertension, particularly in our region.
This annual meeting is a good opportunity to share the most advanced scientific
information with distinguished faculties from USA, Europe and the Arab World as
well as our local Egyptian Experts from different disciplines: internists, nephrologists,
cardiologists and pediatricians. I am confident that your contribution will enrich the
scientific discussion and exchange of experiences.
I am looking forward to seeing you in Cairo during this meeting.

Chairman of the Meeting

Mohamed Oraby ,MD
Prof. of Cardiology Suez Canal University
3

EHS Meeting 2014

Organizing Committee
(Alphabetical)

Suez Canal
USA
Cairo
Cairo
Suez Canal
Ain Shams
Cairo
Cairo

Fathy Maklady, MD
Helmy Siragy, MD
Hussein Rizk, MD
M. Mohsen Ibrahim, MD
Mohamed Oraby, MD
Omar Awad, MD
Soliman Ghareeb, MD
Wafaa El-Aroussy, MD

Scientific Committee
(Alphabetical)

Abdel Fattah Frere, MD

Abdel Moniem Ibrahim, MD
Adel El-Etriby, MD
Adel Mazen, MD
Ahmed Abdel Latif Ramadan, MD
Ahmed El-Ghalid, MD
Ahmed El-Hawary, MD
Ahmed Hassan, MD
Ahmed Kamal Motawie, MD
Ahmed Nassar, MD
Ahmed Roza, MD
Ahmed Shafie Ammar, MD
Ahmed Shawky, MD
Ahmed Tag, MD
Ali Ramzy, MD
Ashraf Reda, MD
Atef El-Bahary, MD
Aziz Madkour, MD
Azza Farrag, MD
Azza El-Eraky, MD
Ebtihag Hamdy, MD
Eman El Safty, MD
Essam Mahfouz, MD
Ezz El-Sawy, MD
Fathy
4 Maklady, MD

Zagazig
Cairo
Ain Shams
Al-Azhar
Al-Azhar
Suez Canal
Suez Canal
Suez Canal
Azhar
Ain Shams
Al-Azhar
Zagazig
Ain Shams
Suez Canal
Ain Shams
Menofia
Port Said
Al-Azhar
Cairo
Suez Canal
Alexandria
Mansoura
Mansoura
Al-Azhar
Suez Canal

EHS Meeting 2014

Gamal Aboul Nasr, MD
Gamela Nasr, MD
Hamdy Soliman, MD
Hanan Kamal, MD
Hany Ragy, MD
Hesham Aboul Enien, MD
Hesham Hegazy, MD
Hossam El Shaier, MD
Hossam Kandil, MD
Hussein Rizk, MD
Karim Said, MD
Khairy Abdel Dayem, MD
M. Mohsen Ibrahim, MD
Magdy El-Masry, MD
Mai Hamdy El Sayed, MD
Mohamed Abdel Ghany, MD
Mohamed Awad Taher, MD
Mohamed Gamal, MD
Mohamed Oraby, MD
Mohamed Sleem, MD
Mohamed Sobhy, MD
Mohamed Wafaie, MD
Mokhtar Gomaa, MD
Nashwa El-Hagrasy
Nasser Taha, MD
Nermine Sheriba, MD
Omar Awaad, MD
Omar El-Khashab, MD
Osama Sanad, MD
Ragab Abdel Salam, MD
Ramzy El-Mawardy, MD
Sameh Allam, MD
Sameh Shaheen, MD
Sherif El Tobgy, MD
Soliman Ghareeb, MD
Wafaa El-Aroussy, MD
Wagdy Ayad, MD
Wagdy Galal, MD
Yehia Kishk, MD

NHI
Suez Canal
NHI
Suez Canal
NHI
Banha
Suez Canal
Zagazig
Cairo
Cairo
Cairo
Ain Shams
Cairo
Tanta
Ain Shams
Cairo
Ain Shams
Assiut
Suez Canal
NHI
Alexandria
Zagazig
Al-Azhar
6th October
Menia
Ain Shams
Ain Shams
Cairo
Banha
Zagazig
Ain Shams
Al-Azhar
Ain Shams
Cairo
Cairo
Cairo
Alexandria
Ain Shams
Assuit

EHS Meeting 2014

International Faculty
(Alphabetical)

Mohamed Adel Khedr, MD

Professor of Nephrology; Hospital Charles Nicolle; Tunisia
Charles Adib Jazra MD
Graduated from the French Faculty of Medicine in Beirut
1974. Training in Cardiology at Nancy France 1977
Associate Fellow of the ACC 1998
Past president of the Lebanese Society of Cardiology
Chief of Cardiology department St. Joseph Hospital Beirut
Lebanon He is organizing every second year one of the most
important meeting Middle East Cardiopace a joint
meeting between electrophysiology and prevention of CHD
and stroke.

Helmy M. Siragy, MD, FACP, FAHA

Harrison Distinguished Chair of Excellence in Medical

Education Professor of Medicine and Endocrinology,
Associate Chief, Department of Medicine
Director of the Hypertension Research Center at the
University of Virginia, Charlottesville, Virginia, USA.
His primary research interests are in the areas of
Hypertension and the Renin-Angiotensin System, Adrenal
diseases, (Pro)renin Receptors, and Diabetic Nephropathy.

Osama Okkeh, MD

consultant Cardiologist based in Jordan. After graduation in

General Medicine at the beginning of the eighties at Baghdad
University College of Medicine, trained at the teaching hospital
of the university. Travelled to London on 1983 and gained the
MRCP, then Egypt (Alexandria) achieving the masters degree in
cardiology and then Ph.D. London. Ex- president of the
Jordanian Lipid Society (JLS) Established the Jordanian
Hypertension Society (JHS) and merged both societies in the
Jordanian Atherosclerosis & Hypertension Society (JAHS).
Current interests are pathophysiology and management of hypertension and dyslipidemia
and their relationship to coronary ischemic syndromes.

EHS Meeting 2014

Paul K. Whelton, MD,

Dr. Whelton spent 26 years in Baltimore, where he was

professor of epidemiology at the Johns Hopkins School
of Hygiene and Public Health, professor of medicine at the
School of Medicine, director of the Outpatient General Clinical
Research Center, and founding director of the Welch Center
for Prevention, Epidemiology, and Clinical Research. In 1997
he moved to New Orleans as dean of the Tulane University
School of Public Health and Tropical Medicine and in 1999
was appointed Senior Vice President for Health Sciences. He
also served as dean of the School of Medicine at Tulane,
president and chair of the Louisiana Gene Therapy Research Consortium, chair of the
Louisiana Cancer Research Consortium, chair of the Louisiana Biomedical Research and
Development Park Commission, and vice-chair of the New OrleansBioInnovation Center. In
2007 he moved to Chicago as President and CEO of the Loyola University Health System
and Medical Center and concurrently served as Senior Vice President for Health Sciences
at Loyola University Chicago where he was professor of preventive medicine and
epidemiology at the Stritch School of Medicine. In 2011 he returned to New Orleans where
he serves as the Show ChwanHealth System Endowed Chair in Global Public Health at the
Tulane University School of Public Health and Tropical Medicine.
Research interests: cardiovascular disease and renal disease epidemiology, prevention,
treatment trials, policy, and global health.

Taysir Said Garadah, MD

Consultant Cardiologist
Head of medical department
Arabian Gulf University
Associate professor in medicine
King Hamad University hospital

EHS Meeting 2014

Tony Heagerty, MD

He is a former President of the European Society of

Hypertension. Until recently he was President of the
International Society of Hypertension (2008-2010) and also
President of the British Hypertension Society (2011-13),
having served as Vice-President since September 2009.
He is a Member of the Nominations Committee for the Royal
College of Physicians and serves on the Boards of the Journal
of Clinical Metabolism & Diabetes, Therapeutic Advances in
Cardiovascular Disease, The Open Cardiovascular Medicine
Journal, Experimental Physiology, Current Hypertension
Reviews, Journal of Hypertension, Hypertension, Diabetes and Vascular Disease Research
and Blood Pressure.
He is an international authority on high blood pressure, aetiology and management.
He holds an Honorary Consultant contract with Central Manchester Foundation Trust
(Manchester Royal Infirmary) and holds regular clinics for the treatment of high blood
pressure as well as General Medicine.

EHS Meeting 2014

General Information
Venue
Fairmont Heliopolis Hotel
Language
All Course sessions are in English; no instant translation.
Registration
Will be open on Wednesday from 8:00 am till 10:00am.
Currency Banking (rates are subject to change)
1 US $ = 7 Egyptian Pounds
- 1 = 9 Egyptian Pounds
Weather Forecast
Temperature during the conference days is expected to be:
Low: 13oC
High: 27oC
Parking
Parking inside the hotel with special fees that you will have to settle it by yourself
All Names in Alphabetical Order
Organizing Office In Charge
Mrs. Fatheya El Said
Email: egy.congress@yahoo.com
Cellular: +201119422298
+201027522200
+201228011197
Telephone:(+202)
26362290 Website:www.egycongress.org

Secretariat Of The Meeting
Mrs. Rehab M. El-Ashkar
The Egyptian Hypertension Society
1 El-Diwan Street, Garden City, Cairo.
Tel.: (202) 794-8877
Fax: (202) 794-8879
E-mail: ehs@link.net
Website: www.ehs-egypt.net

EHS Meeting 2014

Audiovisual & Speakers Instructions

We are delighted to have you as a welcomed speaker and we do appreciate much
to bring out your presentation to the audience in a perfect way. We have a modified system that we ALL have to FOLLOW to keep the integrity of the conference
scientific program.
Please use a PC (IBM Compatible) not Apple Macintosh formats.
The following guidelines are made to help us bringing this conference to perfection
* Computers used in the conference are PCs loaded with Microsoft Office 2007.
* Please use Microsoft PowerPoint XP or later version to prepare your
presentation
* If your presentation includes movies, be sure to create a folder including your
presentation & movie files or sound clips. This will insure that all the tools used
to create the presentation are readily accessible on the show site, should the
need arise to modify the presentation.
* Please remember that your movies should be in MPEG1 format. AVI files might
not work properly on all computers unless special codec is used. MOV is not a
compatible format to be run inside PowerPoint.
* DICOM players will be available in all computers serving the conference.
* Speakers are not allowed to use their personal laptops whatever the reason is.
Strict rule are applied in this matter. Apple users must prepare a PC
compatible CD or DVD loaded with their presentation(s).
* Only digital media is allowed as a tool to present data, namely CDs, DVDs,
Flash memory &/or external hard drive. No 35mm physical slides are allowed.
No video tapes. No Transparencies. No Whiteboard. No Bluetooth mobile
phones.
* Computers inside halls are not connected to the internet.
* Speakers MUST handle their PRESENTATION CDs 1 hour AT LEAST before
beginning of the session.
* The duration of the presentation is controlled digitally through computer soft
ware that will end the view when time is up, thus we value your understanding
to stick to the dedicated time.
10

EHS Meeting 2014

Companies Acknowledgement
The Organizing Committee expresses their deep thanks and gratitude to the
industry participants who played a major role in bringing this event to light

11

EHS Meeting 2014

Wednesday 9th April 2014

10:00 10:30
Chairpersons:
Fathy Maklady, MD
Sherif El Tobhy, MD
10:00-10:30

Session 1: State of the art

Khairy Abdel Dayem, MD

Pharmacologic treatment of hypertension:

Middle Eastern prospective

Mokhtar Gomaa, MD
M. Mohsen Ibrahim, MD

10:30 11:30
Session 2
New Hypertension Guidelines: What is new in the new?
Chairpersons:
Ahmed Roza, MD
Aziz Madkour, MD
Soliman Ghareeb, MD
10:30-10:45
10:50-11:05
11:10-11:25

Egyptian Guidelines 2013

Karim Said, MD

European Guidelines 2013

Mohamed Wafaie, MD

JNC 8

Sameh Shaheen, MD

Each lecture is followed by 5 minutes discussion

11:30 12:00
11:30-11:45

Opening Ceremony
Welcome address

11:45-12:00

Ongoing and future activities of EHS

12:00 12:20

12

M. Mohsen Ibrahim, MD
Mohamed Oraby, MD
Hussien Rizk, MD

1st Coffee Break

EHS Meeting 2014

Wednesday 9th April 2014

12:20 13:05
Session 3: Salt and Hypertension

Chairpersons:
Ashraf Reda, MD
Ramzy El-Mawardy, MD

Essam Mahfouz, MD
Sameh Allam, MD

12:20-12:45 State-of-the-Art: The Salt Dilemma !!

12:45-13:05 Egyptian Salt Survey

Ezz El-Sawy, MD

Paul Whelton, MD
Wafaa El-Aroussy, MD

13:05 14:05
Novartis Symposium
Chairpersons:
Ahmed Kamal Motawie, MD
Mohamed Oraby, MD

M. Mohsen Ibrahim, MD

Omar Awaad, MD

13:05-13:30 The role of triple drug therapy in the

Helmy Siragy, MD
management of hypertensive patients
13:35-14:00 Valsartan for hypertension management: Mohamed Awad Taher, MD
What is beyond blood pressure control?
Each lecture is followed by 5 minutes discussion

14:05 15:25
Session 4: Management Of Hypertension In Difficult Situations
Chairpersons:
Ahmed Abdel Latif Ramadan, MD Ahmed El-Ghalid, MD Gamela Nasr, MD
Osama Sanad, MD
14:05-14:20
14:25-14:40
14:45-15:00
15:05-15:20

Patient with chronic kidney disease

Patient with orthostatic hypotension
Patient with cerebrovascular disease
Pregnant and lactating women

Omar El-Khashab, MD
Tony Heagarty, MD
Mohamed Abdel Ghany, MD
Hesham Aboul Enien, MD

Each lecture is followed by 5 minutes discussion

15:25 15:45

2nd Coffee Break

13

EHS Meeting 2014

Wednesday 9th April 2014

15:45 16:50
Chairpersons:
Fathy Maklady, MD
Yehia Kishk, MD
15:45-16:10

Session 5
Mohamed Oraby, MD Taysir Garadah, MD

(A) State-of-the-Art
Hypotension: What hypertension
specialist needs to know

Helmy Siragy, MD

(B) Debate: Systolic BP target should be <130 or < 150 mmHg

16:10-16:25 Target should be higher
Nasser Taha, MD
16:25-16:40 Target should be lower
Ahmed Hassan, MD
16:40-16:50 Rebuttle

16:50 17:35
Session 6: Round Table Discussion

Moderator:
Hussein Rizk, MD
Panelists:
Hany Ragy, MD
Tony Heagarty, MD
16:50-17:35

Omar Awad, MD

Paul whelton, MD

Beyond blood pressure reduction : the management of global

CV risk

17:3517:50
17:35-17:50

Community Activities
The real community Service
17:50

14

Lunch

Soliman Ghareeb, MD

EHS Meeting 2014

15

EHS Meeting 2014

16

EHS Meeting 2014

Thursday 10th April 2014

9:00 10:00
Session 1: Case Presentations

Chairpersons:
Adel Mazen, MD
Mohamed Gamal, MD
9:00-9:10
9:15-9:25
9:30-9:40
9:45-9:55

Magdy El-Masry, MD
Ragab Abdel Salam, MD

Case presentation 1
Case presentation 2
Case presentation 3
Case presentation 4

Hamdy Soliman, MD
Azza Farrag, MD
Mohamed Sleem, MD
Ahmed Shawky, MD
Azza El-Eraky, MD

Each case will be followed by 5 minutes discussion

10:00 10:25
Chairpersons:
Ahmed El-Hawary, MD
Wagdy Ayad, MD

Session 2: State-of-the-art
Essam Mahfouz, MD

10:00-10:25 Obesity-related hypertension :

Evidence-based approach

Mohamed Adel Khedr, MD

Helmy Siragy, MD

17

EHS Meeting 2014

Thursday 10th April 2014

10:25 11:25
Session 3: Miscellaneous

Chairpersons:
Ahmed Shafie Ammar, MD
Nashwa El-Hagrasy, MD

Atef El-Bahary, MD

Ebtihag Hamdy, MD

10:25-10:40 Mind and Hypertension.

Omar Awaad, MD
10:45-11:00 arterial stiffness: value and assessment
Abdel Moniem Ibrahim, MD
11:05-11:20 Pitfalls and misconcepts in the diagnosis Soliman Ghareeb, MD
and management of Hypertension
Each lecture is followed by 5 minutes discussion

11:25 11:45

1st Coffee Break

11:45 12:25
Astra Zeneca Symposium

Chairpersons:
Ahmed Nassar, MD Mai Hamdy El Sayed, MD
Wagdy Galal, MD

Mohamed Awad Taher, MD

11:45-12:00 Hypertension to Heart Failure

12:05-12:20 New Guidelines update in Dyslipidemia
& Diabetes Management

18

Hussien Rizk, MD
Nermine Sheriba, MD

EHS Meeting 2014

Thursday 10th April 2014

12:25 13:05
Debate
Drug Treatment of Hypertension: Does Drug Class Matter?
Chairpersons:
Abdel Fattah Frere, MD
Hussein Rizk, MD
12:25-12:40
12:40-12:55
12:55-13:05

Ali Ramzy, MD

Yes. It does matter.

No. It is all about BP reduction.
Rebuttle

Charles Jazara, MD
Hossam Kandil, MD
Tony Hegarty, MD

13:05 14:35
Chairpersons:
Eman El Safty,MD
Hossam El Shaier, MD
13:05-13:30

Session 4
Hanan Kamal, MD
Hesham Hegazy, MD
Osama Okkah, MD

(A) State-of-the-Art
BP reduction: how low should we go?

Paul Whelton, MD

(B) Unresolved issues in HTN

13:35-13:50 BP variability: when and how to treat?
Ahmed El-Hawary, MD
13:55- 14:10 Renal artery stenting: live or dead?!
Adel El-Etriby, MD
14:15- 14:30 Clinical and biochemical predictors of
M. Mohsen Ibrahim, MD
hypertension
Each lecture is followed by 5 minutes discussion

14:35 14:55

2nd Coffee Break

19

EHS Meeting 2014

Thursday 10th April 2014

14:55 15:40
Session 5: Round Table Discussion
Moderator: Fathy Maklady, MD
Panelists: Gamal Aboul Nasr, MD
Helmy Siragy, MD
Hesham Hegazy, MD
Mohamed Sobhy, MD
14:55-15:40 Renal sympathetic denervation a new horizon in the management
of Resistant HTN : A hype or hope?

15:40 16:40
Session 6: Hypertension in the Arab World
Chairpersons:
Charles Jazara, MD
M. Mohsen Ibrahim, MD
Mohamed Adel Khedr, MD
Osama Okkah, MD
Taysir Garadah, MD
15:40-15:50
15:50-16:00
16:00-16:10
16:10-16:20
16:20-16:30
16:30-16:40

Egypt
Lebanon
Bahrain
Jordan
Tunisia
Towards a regional Arab hypertension
guidelines.

M. Mohsen Ibrahim, MD
Charles Jazara, MD
Taysir Garadah, MD
Osama Okkah, MD
Mohamed Adel Khedr, MD
Panel discussion

16:40 17:10
Closing Remarks
16:40-16:50 Meeting in Minutes
16:50-17:00 Future plans & Actions
17:00-17:10 Thank-You note

17:10
20

Ahmed Tag, MD
Omar Awad, MD
M. Mohsen Ibrahim, MD
Mohamed Oraby, MD
Lunch & Adjourn

Note
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................

Note
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................

Note
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................
.................................................................................................................................